X-linked adrenoleukodystrophy (X-ALD) is a debilitating disease caused by mutations in the ABCD1 gene. Approximately 30% of affected boys develop the progressive ...

Viking Therapeutics has announced positive results from its Phase Ib clinical trial of VK0214, a thyroid hormone receptor ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

Considering taking supplements to treat adrenoleukodystrophy ald? Below is a list of common natural remedies used to treat or reduce the symptoms of adrenoleukodystrophy ald. Follow the links to ...

X-Linked Adrenoleukodystrophy (ALD) is a rare genetic disorder that breaks down myelin, the protective sheath that surrounds the brain and spinal cord. Early intervention and regular screenings ...

Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners ...